person

Iwona K. G.

Country
Poland
Department
Medicome Sp. z o.o.

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 5 partner sites.

Specializations

Cardiovascular & Metabolic Disorders

The investigator focuses on conditions such as acute coronary syndrome, atrial fibrillation, heart failure, and atherosclerotic cardiovascular disease together with metabolic challenges like obesity and mixed dyslipidemia.

  • Myocardial infarction
  • Hypertension
  • Cardiovascular mortality reduction
  • Weight management in overweight patients

Research integrates cardiovascular risk mitigation with metabolic health improvement.

Inflammatory Bowel Diseases

Active involvement includes therapeutic exploration for Crohn's disease and ulcerative colitis, addressing both induction and maintenance phases.

  • Clinical remission in Crohn's disease
  • Endoscopic response in ulcerative colitis
  • Long‑term safety of novel agents

Efforts aim at durable disease control and mucosal healing.

Chronic Urticaria & Dermatologic Conditions

The investigator evaluates treatments for chronic spontaneous urticaria, chronic inducible urticaria, and related dermographic disorders.

  • Urticaria activity score reduction
  • Negative provocation test achievement
  • Safety in dermatologic populations

Work emphasizes symptom relief and quality‑of‑life improvement.

Respiratory & Pulmonary Diseases

Research spans asthma, chronic obstructive pulmonary disease, and broader inflammatory lung disease contexts.

  • Reduction of exacerbations
  • Improvement in lung function parameters
  • Evaluation of anti‑inflammatory strategies

Goals include enhanced respiratory stability and reduced disease burden.

Neurodegenerative & Cognitive Disorders

Interest extends to early stages of Alzheimer's disease with inflammatory biomarkers.

  • Cognitive performance preservation
  • Biomarker‑driven therapeutic assessment
  • Safety in early disease populations

Focus is on slowing cognitive decline through targeted interventions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.